A new study using MRI shows that smoking damages key areas of the brain involved in memory and thinking, and that being overweight may increase the damage, raising new questions about dementia prevention.
Scientists have discovered that creatine can do more than just build muscle: it boosts brain resilience, improves mood, and supports cognitive function through biochemical pathways activated by exercise.
The origin of some neuropsychiatric disorders such as autism, bipolar disorder or depression, as well as some neurodegenerative diseases such as Alzheimer's and Parkinson's disease, may lie in the very early stages of brain development in the fetus.
A major breakthrough in prostate cancer research: A first-of-its-kind study by Emory University researchers has revealed how the disease evolves into its most deadly form and identified a promising treatment strategy.
YourChoice Therapeutics, in partnership with Quotient Sciences and Incyte, reports that single oral doses of the investigational non-hormonal male contraceptive YCT-529 up to 180 mg did not result in clinically significant safety concerns in 16 healthy men.
Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has joined 40 other centers in the U.S. and Europe as a participant in one of the country's first clinical trials of cell therapy for autoimmune diseases.
A potential target for experimental drugs that block PRMT5, a natural enzyme that some tumors particularly rely on for survival, has been identified by scientists at the Fralin Biomedical Institute Cancer Research Center in Washington.
Overcoming insecticide resistance: How a single gene modification in mosquitoes self-propagates across generations, virtually eliminating malaria transmission without compromising survival.
